Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells

類似資料

• CD8 T cells utilize TNF-related apoptosis-inducing ligand (TRAIL) to control influenza virus infection
  著者:: Brincks, Erik L., 等
  出版事項: (2008)
• Systemic immunological tolerance to ocular antigens is mediated by TNF-related apoptosis-inducing ligand (TRAIL)-expressing CD8(+) T cells
  著者:: Griffith, Thomas S., 等
  出版事項: (2010)
• Influenza-induced expression of functional TNF-related apoptosis-inducing ligand (TRAIL) on human PBMC
  著者:: Brincks, Erik L., 等
  出版事項: (2008)
• CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma
  著者:: James, Britnie R., 等
  出版事項: (2014)
• TRAIL-expressing CD8(+) T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion
  著者:: Gurung, Prajwal, 等
  出版事項: (2010)